View the clinical evidence supporting the use of Vidium’s diagnostic tests.
Ehrhart EJ, et al. Polymerase chain reaction for antigen receptor rearrangement: Benchmarking performance of a lymphoid clonality assay in diverse canine sample types.
This study describes the performance (accuracy, sensitivity, and specificity) and rigorous benchmarking of a PARR protocol (ePARR) in
clinically relevant samples.
Wong S, Warrier M, Byron S, et al. Design, analytical validation and diagnostic yield of a novel canine cancer gene sequencing panel.
This conference poster presentation details the validation process for SearchLight DNA.
A Survey of Canine Cancer Genomic Biomarkers Based on Structured Literature Review, Meta-Analysis, and Comparative Genomics
This presentation shows how Vidium Animal Health constructed a canine cancer genomic biomarker database through systematic review, meta-analysis and harmonization of cancer mutation data from canine and human sources.
Tumor Genomic Analysis for Diagnostically Challenging Cancer Cases
Explore the clinical utility of genomics in diagnostically challenging oncology cases. Genomic Analysis with SearchLight DNA can provide valuable diagnostic, prognostic and therapeutic information in over 80% of these cases.